BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 4138631)

  • 1. Iodine-induced toxic diffuse goitre.
    Liewendahl K; Gordin A
    Acta Med Scand; 1974 Sep; 196(3):237-9. PubMed ID: 4138631
    [No Abstract]   [Full Text] [Related]  

  • 2. Changes in serum TSH and T4 after T3 suppression tests in patients treated for hyperthyroidism due to Graves' disease.
    Suematsu H; Tamai H; Esaki M; Kurokawa N; Aoki H; Matsuzuka F; Miyauchi A; Kuma K
    J Clin Endocrinol Metab; 1977 Nov; 45(5):1013-8. PubMed ID: 579181
    [No Abstract]   [Full Text] [Related]  

  • 3. Laboratory examination of the thyroid. 1. In vitro tests.
    Schneider PB
    Postgrad Med; 1974 Aug; 56(2):91-6. PubMed ID: 4136847
    [No Abstract]   [Full Text] [Related]  

  • 4. Equine goiter due to excess dietary iodide.
    Baker HJ; Lindsey JR
    J Am Vet Med Assoc; 1968 Dec; 153(12):1618-30. PubMed ID: 4177826
    [No Abstract]   [Full Text] [Related]  

  • 5. [Thyrotropic hormone and the thyroid gland (present status)].
    Kalinin AP; Izmaĭlov GI
    Ter Arkh; 1977; 49(12):131-7. PubMed ID: 414369
    [No Abstract]   [Full Text] [Related]  

  • 6. [Total and free thyroxine in certain thyroid diseases (preliminary report)].
    Vurbanov V; Stancheva M; Strashimirov D
    Vutr Boles; 1974; 13(4):69-76. PubMed ID: 4141188
    [No Abstract]   [Full Text] [Related]  

  • 7. Correlation of long-acting thyroid stimulator with serum levels of tri-iodothyronine, thyroxine and thyrotropin in Graves' disease.
    Sawhney RC; Kannan V; Rastogi GK
    J Assoc Physicians India; 1975 Feb; 23(2):111-4. PubMed ID: 1242389
    [No Abstract]   [Full Text] [Related]  

  • 8. [Toxic adenoma of the thyroid gland].
    Schneck O; Eber O; Wascher H
    Wien Z Inn Med; 1966 Jul; 47(7):261-77. PubMed ID: 4187164
    [No Abstract]   [Full Text] [Related]  

  • 9. Thyroid gland suppressibility in patients treated with radioiodine for diffuse toxic goiter.
    Burgos FL; Micames C; Rivera JV
    Bol Asoc Med P R; 1983 Apr; 75(4):173-5. PubMed ID: 6575791
    [No Abstract]   [Full Text] [Related]  

  • 10. Factors influencing the relationship between labelled triiodothyronine and thyroxine levels in the serum of patients with Graves' disease.
    Földes J; Gyertyánfy G; Tako J; Bános C; Gesztesi E
    Endokrinologie; 1973 Jan; 61(1):52-64. PubMed ID: 4739850
    [No Abstract]   [Full Text] [Related]  

  • 11. Iodide-induced goitre and hypothyroidism in a patient with chronic lymphocytic thyroiditis.
    Liewendahl K; Turula M
    Acta Endocrinol (Copenh); 1972 Oct; 71(2):289-96. PubMed ID: 4116052
    [No Abstract]   [Full Text] [Related]  

  • 12. Interpretation of serum tri-iodothyronine levels measured by the sterling technic.
    Wahner HW; Gorman CA
    N Engl J Med; 1971 Feb; 284(5):225-30. PubMed ID: 4992676
    [No Abstract]   [Full Text] [Related]  

  • 13. Triiodothyronine suppression tests and TSH-releasing hormone tests before and after I- 131 therapy for Graves' disease.
    Tamai H; Nakagawa T; Takahashi H; Ohsako N; Fukino O; Shinzato R; Suematsu H; Matsuzuka F; Kuma K; Nagataki S
    J Nucl Med; 1980 Mar; 21(3):240-5. PubMed ID: 6892713
    [No Abstract]   [Full Text] [Related]  

  • 14. Total and free triiodothyronine and thyroxine levels in thyroid storm and recurrent hyperthydroidism.
    Jacobs HS; Mackie DB; Eastman CJ; Ellis SM; Ekins RP; McHardy-Young S
    Lancet; 1973 Aug; 2(7823):236-8. PubMed ID: 4124425
    [No Abstract]   [Full Text] [Related]  

  • 15. [Serum free thyroxine after 131I therapy for Graves' disease (author's transl)].
    Saito S; Sakurada T; Fukazawa H; Yoshida K; Kaise N; Kitaoka H; Yamamoto M; Kaise K
    Kaku Igaku; 1981 Dec; 18(10):1421-4. PubMed ID: 6896222
    [No Abstract]   [Full Text] [Related]  

  • 16. Unresponsiveness to thyrotropin-releasing hormone (TRH) in treated Graves' hyperthyroidism and in euthyroid Graves' disease.
    Clifton-Bligh P; Silverstein GE; Burke G
    J Clin Endocrinol Metab; 1974 Apr; 38(4):531-8. PubMed ID: 4206830
    [No Abstract]   [Full Text] [Related]  

  • 17. Thyrotropin-releasing hormone (a test to diagnose Graves' ophthalmopathy).
    Hyman BN; Johnson PC
    Trans Sect Ophthalmol Am Acad Ophthalmol Otolaryngol; 1975; 79(3 Pt 2):OP524-8. PubMed ID: 50663
    [No Abstract]   [Full Text] [Related]  

  • 18. The plasma inorganic iodine and the pituitary-thyroid axis in pregnancy.
    Koutras DA; Pharmakiotis AD; Koliopoulos N; Tsoukalos J; Souvatzoglou A; Sfontouris J
    J Endocrinol Invest; 1978 Jul; 1(3):227-31. PubMed ID: 117043
    [No Abstract]   [Full Text] [Related]  

  • 19. Hyperthyroidism due to Graves-Basedow disease in a woman refractory to thyroid hormones.
    González Cabrera N; Kalic AK; Antón Miguel MÁ; Sierra Polo P; Vicente Vicente MÁ
    Endocrinol Nutr; 2012 Dec; 59(10):609-11. PubMed ID: 22425314
    [No Abstract]   [Full Text] [Related]  

  • 20. The relationship of thyroxine turnover to other parameters of peripheral thyroid function in Graves' disease.
    Clifton-Bligh P; Burke G
    J Lab Clin Med; 1975 Jun; 85(6):922-33. PubMed ID: 48532
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.